Table 3 |
|||
|
ES at rest in the patients who were ES-positive during Valsalva |
|||
|
Stroke Subtypes |
ES-Positive at Rest, n (%) |
ES-Negative at Rest, n (%) |
Difference P-value |
|
|
|||
|
Male patients (n = 140) |
|||
|
Atherothrombotic |
8 (50.0) |
8 (50.0) |
1.000 |
|
Cardioembolic |
16 (57.1) |
12 (42.9) |
0.291 |
|
Lacunar |
13 (40.6) |
19 (59.4) |
0.427 |
|
Other |
2 (57.1) |
5 (42.9) |
0.447 |
|
Unknown |
27 (47.4) |
30 (52.6) |
1.000 |
|
Female patients (n = 114) |
|||
|
Atherothrombotic |
6 (40.0) |
9 (60.0) |
1.000 |
|
Cardioembolic |
10 (52.6) |
9 (47.4) |
0.201 |
|
Lacunar |
8 (38.1) |
13 (61.9) |
1.000 |
|
Other |
4 (50.0) |
4 (50.0) |
0.709 |
|
Unknown |
16 (31.4) |
35 (68.6) |
0.179 |
|
|
|||
|
Poppert et al. Journal of Negative Results in BioMedicine 2008 7:7 doi:10.1186/1477-5751-7-7 |
|||
